ブピバカインリポソーム注射液の世界市場に関する洞察、2030年までの予測

当レポートは、ブピバカインリポソーム注射液 (Bupivacaine Liposome Injection) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

• ブピバカインリポソーム注射液の製品概要
• 市場：タイプ別
  • 世界のブピバカインリポソーム注射液の市場規模成長率：タイプ別, 2019 VS 2023 VS 2030
  • 133mg per Vial
  • 266mg per Vial
• 市場：用途別
  • 世界のブピバカインリポソーム注射液の市場規模成長率：用途別, 2019 VS 2023 VS 2030
  • Local Anesthesia
  • Postoperative Analgesia
  • Other
• 前提条件と制限
• 調査目的
• 対象期間

第2章 レポート概要

• 世界のブピバカインリポソーム注射液の収益 推定および予測 2019-2030
• 世界のブピバカインリポソーム注射液の収益：地域別
  • 世界のブピバカインリポソーム注射液の収益：地域別: 2019 VS 2023 VS 2030
  • 世界のブピバカインリポソーム注射液の収益：地域別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の収益：地域別 (2025-2030)
  • 世界のブピバカインリポソーム注射液の収益市場シェア 地域別 (2019-2030)
• 世界のブピバカインリポソーム注射液 売上予測・予想 2019-2030
• 世界のブピバカインリポソーム注射液の販売：地域別
  • 世界のブピバカインリポソーム注射液の販売：地域別: 2019 VS 2023 VS 2030
  • 世界のブピバカインリポソーム注射液の販売：地域別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の販売：地域別 (2025-2030)
  • 世界のブピバカインリポソーム注射液の販売市場シェア 地域別 (2019-2030)
• 米国・カナダ
• 欧州
• 中国
• アジア（中国を除く）
• 中東, アフリカ ・ラテンアメリカ

第3章 競合：企業別

• 世界のブピバカインリポソーム注射液の販売：企業別
  • 世界のブピバカインリポソーム注射液の販売：企業別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の販売市場シェア：企業別 (2019-2024)
  • 世界の上位10・上位5企業： ブピバカインリポソーム注射液 in 2023
• 世界のブピバカインリポソーム注射液の収益：企業別
  • 世界のブピバカインリポソーム注射液の収益：企業別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の収益市場シェア：企業別 (2019-2024)
  • 世界の上位10・上位5企業： ブピバカインリポソーム注射液の収益 2023
• 世界の主要企業 ブピバカインリポソーム注射液, 業界ランキング, 2021 VS 2022
• 世界のブピバカインリポソーム注射液の販売価格：企業別 (2019-2024)
• 競合情勢の分析
  • 企業の市場集中度 (CR5 and HHI)
  • 世界のブピバカインリポソーム注射液の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
• 世界の主要メーカー ブピバカインリポソーム注射液, 製造拠点分布と本社
• 世界の主要メーカー ブピバカインリポソーム注射液, 提供製品と用途
• 世界の主要メーカー ブピバカインリポソーム注射液, 業界参入時期
• M&A, 拡張計画

第4章 市場規模：タイプ別

• 世界のブピバカインリポソーム注射液の販売：タイプ別
  • 世界のブピバカインリポソーム注射液の販売実績：タイプ別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の販売予測：タイプ別 (2025-2030)
  • 世界のブピバカインリポソーム注射液の販売市場シェア：タイプ別 (2019-2030)
• 世界のブピバカインリポソーム注射液 収益：タイプ別
  • 世界のブピバカインリポソーム注射液の収益実績：タイプ別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の収益予測：タイプ別 (2025-2030)
  • 世界のブピバカインリポソーム注射液の収益市場シェア：タイプ別 (2019-2030)
• 世界のブピバカインリポソーム注射液の価格：タイプ別
  • 世界のブピバカインリポソーム注射液の価格：タイプ別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の価格予測：タイプ別 (2025-2030)

第5章 市場規模：用途別

• 世界のブピバカインリポソーム注射液の販売：用途別
  • 世界のブピバカインリポソーム注射液の販売実績：用途別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の販売予測：用途別 (2025-2030)
  • 世界のブピバカインリポソーム注射液の販売市場シェア：用途別 (2019-2030)
• 世界のブピバカインリポソーム注射液の収益：用途別
  • 世界のブピバカインリポソーム注射液の収益実績：用途別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の収益予測：用途別 (2025-2030)
  • 世界のブピバカインリポソーム注射液の収益市場シェア：用途別 (2019-2030)
• 世界のブピバカインリポソーム注射液の価格：用途別
  • 世界のブピバカインリポソーム注射液の価格：用途別 (2019-2024)
  • 世界のブピバカインリポソーム注射液の価格予測：用途別 (2025-2030)

第6章 米国・カナダ

• 米国・カナダ ブピバカインリポソーム注射液 市場規模：タイプ別
  • 米国・カナダ ブピバカインリポソーム注射液の販売：タイプ別 (2019-2030)
  • 米国・カナダ ブピバカインリポソーム注射液 収益：タイプ別 (2019-2030)
• 米国・カナダ ブピバカインリポソーム注射液 市場規模：用途別
  • 米国・カナダ ブピバカインリポソーム注射液の販売：用途別 (2019-2030)
  • 米国・カナダ ブピバカインリポソーム注射液の収益：用途別 (2019-2030)
• 米国・カナダ ブピバカインリポソーム注射液 市場規模：国別
  • 米国・カナダ ブピバカインリポソーム注射液の収益：国別: 2019 VS 2023 VS 2030
  • 米国・カナダ ブピバカインリポソーム注射液の収益：国別 (2019-2030)
  • 米国・カナダ ブピバカインリポソーム注射液の販売：国別 (2019-2030)
  • US
  • カナダ

第7章 欧州

• 欧州のブピバカインリポソーム注射液 市場規模：タイプ別
  • 欧州のブピバカインリポソーム注射液の販売：タイプ別 (2019-2030)
  • 欧州のブピバカインリポソーム注射液 収益：タイプ別 (2019-2030)
• 欧州のブピバカインリポソーム注射液 市場規模：用途別
  • 欧州のブピバカインリポソーム注射液の販売：用途別 (2019-2030)
  • 欧州のブピバカインリポソーム注射液の収益：用途別 (2019-2030)
• 欧州のブピバカインリポソーム注射液 市場規模：国別
  • 欧州のブピバカインリポソーム注射液の収益：国別: 2019 VS 2023 VS 2030
  • 欧州のブピバカインリポソーム注射液の収益：国別 (2019-2030)
  • 欧州のブピバカインリポソーム注射液の販売：国別 (2019-2030)
  • ドイツ
  • フランス
  • 英国
  • イタリア
  • ロシア

第8章 中国

• 中国のブピバカインリポソーム注射液 市場規模：タイプ別
  • 中国のブピバカインリポソーム注射液の販売：タイプ別 (2019-2030)
  • 中国のブピバカインリポソーム注射液 収益：タイプ別 (2019-2030)
• 中国のブピバカインリポソーム注射液 市場規模：用途別
  • 中国のブピバカインリポソーム注射液の販売：用途別 (2019-2030)
  • 中国のブピバカインリポソーム注射液の収益：用途別 (2019-2030)

第9章 アジア（中国を除く）

• アジア地域 ブピバカインリポソーム注射液 市場規模：タイプ別
  • アジア地域 ブピバカインリポソーム注射液の販売：タイプ別 (2019-2030)
  • アジア地域 ブピバカインリポソーム注射液 収益：タイプ別 (2019-2030)
• アジア地域 ブピバカインリポソーム注射液 市場規模：用途別
  • アジア地域 ブピバカインリポソーム注射液の販売：用途別 (2019-2030)
  • アジア地域 ブピバカインリポソーム注射液の収益：用途別 (2019-2030)
• アジア地域 ブピバカインリポソーム注射液 市場規模：地域別
  • アジア地域 ブピバカインリポソーム注射液の収益：地域別: 2019 VS 2023 VS 2030
  • アジア地域 ブピバカインリポソーム注射液の収益：地域別 (2019-2030)
  • アジア地域 ブピバカインリポソーム注射液の販売：地域別 (2019-2030)
  • 日本
  • 韓国
  • 台湾
  • 東南アジア
  • インド
  • オーストラリア

第10章 中東, アフリカ ・ラテンアメリカ

• 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液 市場規模：タイプ別
  • 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液の販売：タイプ別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液 収益：タイプ別 (2019-2030)
• 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液 市場規模：用途別
  • 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液の販売：用途別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液の収益：用途別 (2019-2030)
• 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液 市場規模：国別
  • 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液の収益：国別: 2019 VS 2023 VS 2030
  • 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液の収益：国別 (2019-2030)
  • 中東, アフリカ ・ラテンアメリカのブピバカインリポソーム注射液の販売：国別 (2019-2030)
  • ブラジル
  • メキシコ
  • トルコ
  • イスラエル
  • 湾岸協力理事会諸国

第11章 企業プロファイル

• Pacira Pharmaceuticals
• Jiangsu Hengrui Pharma

第12章 業界チェーンと販売チャネルの分析

• ブピバカインリポソーム注射液 業界チェーン分析
• ブピバカインリポソーム注射液 主要原材料
  • 主要原材料
  • 原材料の主要サプライヤー
• ブピバカインリポソーム注射液 生産形態とプロセス
• ブピバカインリポソーム注射液 販売およびマーケティング
  • ブピバカインリポソーム注射液 販売チャネルs
  • ブピバカインリポソーム注射液 卸業者
• ブピバカインリポソーム注射液 顧客

第13章 ブピバカインリポソーム注射液 市場動向

• ブピバカインリポソーム注射液 業界動向
• ブピバカインリポソーム注射液 市場の促進要因
• ブピバカインリポソーム注射液 市場の課題
• ブピバカインリポソーム注射液 市場の抑制要因

第14章 主な調査結果 世界のブピバカインリポソーム注射液の主な市場調査結果

第15章 付録

List of Tables

Table 1. Global Bupivacaine Liposome Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of 133mg per Vial

Table 3. Major Manufacturers of 266mg per Vial

Table 4. Global Bupivacaine Liposome Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 5. Global Bupivacaine Liposome Injection Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Bupivacaine Liposome Injection Revenue by Region (2019-2024) & (US$ Million)

Table 7. Global Bupivacaine Liposome Injection Revenue by Region (2025-2030) & (US$ Million)

Table 8. Global Bupivacaine Liposome Injection Revenue Market Share by Region (2019-2024)

Table 9. Global Bupivacaine Liposome Injection Revenue Market Share by Region (2025-2030)

Table 10. Global Bupivacaine Liposome Injection Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Table 11. Global Bupivacaine Liposome Injection Sales by Region (2019-2024) & (K Units)

Table 12. Global Bupivacaine Liposome Injection Sales by Region (2025-2030) & (K Units)

Table 13. Global Bupivacaine Liposome Injection Sales Market Share by Region (2019-2024)

Table 14. Global Bupivacaine Liposome Injection Sales Market Share by Region (2025-2030)

Table 15. Global Bupivacaine Liposome Injection Sales by Manufacturers (2019-2024) & (K Units)

Table 16. Global Bupivacaine Liposome Injection Sales Share by Manufacturers (2019-2024)

Table 17. Global Bupivacaine Liposome Injection Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 18. Global Bupivacaine Liposome Injection Revenue Market Share by Manufacturers (2019-2024)

Table 19. Global Key Players of Bupivacaine Liposome Injection, Industry Ranking, 2021 VS 2022 VS 2023

Table 20. Bupivacaine Liposome Injection Price by Manufacturers (2019-2024) & (US$/Unit)

Table 21. Global Bupivacaine Liposome Injection Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 22. Global Bupivacaine Liposome Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Bupivacaine Liposome Injection as of 2023)

Table 23. Global Key Manufacturers of Bupivacaine Liposome Injection, Manufacturing Base Distribution and Headquarters

Table 24. Global Key Manufacturers of Bupivacaine Liposome Injection, Product Offered and Application

Table 25. Global Key Manufacturers of Bupivacaine Liposome Injection, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Bupivacaine Liposome Injection Sales by Type (2019-2024) & (K Units)

Table 28. Global Bupivacaine Liposome Injection Sales by Type (2025-2030) & (K Units)

Table 29. Global Bupivacaine Liposome Injection Sales Share by Type (2019-2024)

Table 30. Global Bupivacaine Liposome Injection Sales Share by Type (2025-2030)

Table 31. Global Bupivacaine Liposome Injection Revenue by Type (2019-2024) & (US$ Million)

Table 32. Global Bupivacaine Liposome Injection Revenue by Type (2025-2030) & (US$ Million)

Table 33. Global Bupivacaine Liposome Injection Revenue Share by Type (2019-2024)

Table 34. Global Bupivacaine Liposome Injection Revenue Share by Type (2025-2030)

Table 35. Bupivacaine Liposome Injection Price by Type (2019-2024) & (US$/Unit)

Table 36. Global Bupivacaine Liposome Injection Price Forecast by Type (2025-2030) & (US$/Unit)

Table 37. Global Bupivacaine Liposome Injection Sales by Application (2019-2024) & (K Units)

Table 38. Global Bupivacaine Liposome Injection Sales by Application (2025-2030) & (K Units)

Table 39. Global Bupivacaine Liposome Injection Sales Share by Application (2019-2024)

Table 40. Global Bupivacaine Liposome Injection Sales Share by Application (2025-2030)

Table 41. Global Bupivacaine Liposome Injection Revenue by Application (2019-2024) & (US$ Million)

Table 42. Global Bupivacaine Liposome Injection Revenue by Application (2025-2030) & (US$ Million)

Table 43. Global Bupivacaine Liposome Injection Revenue Share by Application (2019-2024)

Table 44. Global Bupivacaine Liposome Injection Revenue Share by Application (2025-2030)

Table 45. Bupivacaine Liposome Injection Price by Application (2019-2024) & (US$/Unit)

Table 46. Global Bupivacaine Liposome Injection Price Forecast by Application (2025-2030) & (US$/Unit)

Table 47. US & Canada Bupivacaine Liposome Injection Sales by Type (2019-2024) & (K Units)

Table 48. US & Canada Bupivacaine Liposome Injection Sales by Type (2025-2030) & (K Units)

Table 49. US & Canada Bupivacaine Liposome Injection Revenue by Type (2019-2024) & (US$ Million)

Table 50. US & Canada Bupivacaine Liposome Injection Revenue by Type (2025-2030) & (US$ Million)

Table 51. US & Canada Bupivacaine Liposome Injection Sales by Application (2019-2024) & (K Units)

Table 52. US & Canada Bupivacaine Liposome Injection Sales by Application (2025-2030) & (K Units)

Table 53. US & Canada Bupivacaine Liposome Injection Revenue by Application (2019-2024) & (US$ Million)

Table 54. US & Canada Bupivacaine Liposome Injection Revenue by Application (2025-2030) & (US$ Million)

Table 55. US & Canada Bupivacaine Liposome Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 56. US & Canada Bupivacaine Liposome Injection Revenue by Country (2019-2024) & (US$ Million)

Table 57. US & Canada Bupivacaine Liposome Injection Revenue by Country (2025-2030) & (US$ Million)

Table 58. US & Canada Bupivacaine Liposome Injection Sales by Country (2019-2024) & (K Units)

Table 59. US & Canada Bupivacaine Liposome Injection Sales by Country (2025-2030) & (K Units)

Table 60. Europe Bupivacaine Liposome Injection Sales by Type (2019-2024) & (K Units)

Table 61. Europe Bupivacaine Liposome Injection Sales by Type (2025-2030) & (K Units)

Table 62. Europe Bupivacaine Liposome Injection Revenue by Type (2019-2024) & (US$ Million)

Table 63. Europe Bupivacaine Liposome Injection Revenue by Type (2025-2030) & (US$ Million)

Table 64. Europe Bupivacaine Liposome Injection Sales by Application (2019-2024) & (K Units)

Table 65. Europe Bupivacaine Liposome Injection Sales by Application (2025-2030) & (K Units)

Table 66. Europe Bupivacaine Liposome Injection Revenue by Application (2019-2024) & (US$ Million)

Table 67. Europe Bupivacaine Liposome Injection Revenue by Application (2025-2030) & (US$ Million)

Table 68. Europe Bupivacaine Liposome Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 69. Europe Bupivacaine Liposome Injection Revenue by Country (2019-2024) & (US$ Million)

Table 70. Europe Bupivacaine Liposome Injection Revenue by Country (2025-2030) & (US$ Million)

Table 71. Europe Bupivacaine Liposome Injection Sales by Country (2019-2024) & (K Units)

Table 72. Europe Bupivacaine Liposome Injection Sales by Country (2025-2030) & (K Units)

Table 73. China Bupivacaine Liposome Injection Sales by Type (2019-2024) & (K Units)

Table 74. China Bupivacaine Liposome Injection Sales by Type (2025-2030) & (K Units)

Table 75. China Bupivacaine Liposome Injection Revenue by Type (2019-2024) & (US$ Million)

Table 76. China Bupivacaine Liposome Injection Revenue by Type (2025-2030) & (US$ Million)

Table 77. China Bupivacaine Liposome Injection Sales by Application (2019-2024) & (K Units)

Table 78. China Bupivacaine Liposome Injection Sales by Application (2025-2030) & (K Units)

Table 79. China Bupivacaine Liposome Injection Revenue by Application (2019-2024) & (US$ Million)

Table 80. China Bupivacaine Liposome Injection Revenue by Application (2025-2030) & (US$ Million)

Table 81. Asia Bupivacaine Liposome Injection Sales by Type (2019-2024) & (K Units)

Table 82. Asia Bupivacaine Liposome Injection Sales by Type (2025-2030) & (K Units)

Table 83. Asia Bupivacaine Liposome Injection Revenue by Type (2019-2024) & (US$ Million)

Table 84. Asia Bupivacaine Liposome Injection Revenue by Type (2025-2030) & (US$ Million)

Table 85. Asia Bupivacaine Liposome Injection Sales by Application (2019-2024) & (K Units)

Table 86. Asia Bupivacaine Liposome Injection Sales by Application (2025-2030) & (K Units)

Table 87. Asia Bupivacaine Liposome Injection Revenue by Application (2019-2024) & (US$ Million)

Table 88. Asia Bupivacaine Liposome Injection Revenue by Application (2025-2030) & (US$ Million)

Table 89. Asia Bupivacaine Liposome Injection Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 90. Asia Bupivacaine Liposome Injection Revenue by Region (2019-2024) & (US$ Million)

Table 91. Asia Bupivacaine Liposome Injection Revenue by Region (2025-2030) & (US$ Million)

Table 92. Asia Bupivacaine Liposome Injection Sales by Region (2019-2024) & (K Units)

Table 93. Asia Bupivacaine Liposome Injection Sales by Region (2025-2030) & (K Units)

Table 94. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales by Type (2019-2024) & (K Units)

Table 95. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales by Type (2025-2030) & (K Units)

Table 96. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Type (2019-2024) & (US$ Million)

Table 97. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Type (2025-2030) & (US$ Million)

Table 98. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales by Application (2019-2024) & (K Units)

Table 99. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales by Application (2025-2030) & (K Units)

Table 100. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Application (2019-2024) & (US$ Million)

Table 101. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Application (2025-2030) & (US$ Million)

Table 102. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 103. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Country (2019-2024) & (US$ Million)

Table 104. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Country (2025-2030) & (US$ Million)

Table 105. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales by Country (2019-2024) & (K Units)

Table 106. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales by Country (2025-2030) & (K Units)

Table 107. Pacira Pharmaceuticals Company Information

Table 108. Pacira Pharmaceuticals Description and Major Businesses

Table 109. Pacira Pharmaceuticals Bupivacaine Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 110. Pacira Pharmaceuticals Bupivacaine Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 111. Pacira Pharmaceuticals Recent Developments

Table 112. Jiangsu Hengrui Pharma Company Information

Table 113. Jiangsu Hengrui Pharma Description and Major Businesses

Table 114. Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 115. Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications

Table 116. Jiangsu Hengrui Pharma Recent Developments

Table 117. Key Raw Materials Lists

Table 118. Raw Materials Key Suppliers Lists

Table 119. Bupivacaine Liposome Injection Distributors List

Table 120. Bupivacaine Liposome Injection Customers List

Table 121. Bupivacaine Liposome Injection Market Trends

Table 122. Bupivacaine Liposome Injection Market Drivers

Table 123. Bupivacaine Liposome Injection Market Challenges

Table 124. Bupivacaine Liposome Injection Market Restraints

Table 125. Research Programs/Design for This Report

Table 126. Key Data Information from Secondary Sources

Table 127. Key Data Information from Primary Sources

List of Figures

Figure 1. Bupivacaine Liposome Injection Product Picture

Figure 2. Global Bupivacaine Liposome Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Bupivacaine Liposome Injection Market Share by Type: 2023 & 2030

Figure 4. 133mg per Vial Product Picture

Figure 5. 266mg per Vial Product Picture

Figure 6. Global Bupivacaine Liposome Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 7. Global Bupivacaine Liposome Injection Market Share by Application: 2023 & 2030

Figure 8. Local Anesthesia

Figure 9. Postoperative Analgesia

Figure 10. Other

Figure 11. Bupivacaine Liposome Injection Report Years Considered

Figure 12. Global Bupivacaine Liposome Injection Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 14. Global Bupivacaine Liposome Injection Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 15. Global Bupivacaine Liposome Injection Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 16. Global Bupivacaine Liposome Injection Revenue Market Share by Region (2019-2030)

Figure 17. Global Bupivacaine Liposome Injection Sales (2019-2030) & (K Units)

Figure 18. Global Bupivacaine Liposome Injection Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (K Units)

Figure 19. Global Bupivacaine Liposome Injection Sales Market Share by Region (2019-2030)

Figure 20. US & Canada Bupivacaine Liposome Injection Sales YoY (2019-2030) & (K Units)

Figure 21. US & Canada Bupivacaine Liposome Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 22. Europe Bupivacaine Liposome Injection Sales YoY (2019-2030) & (K Units)

Figure 23. Europe Bupivacaine Liposome Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 24. China Bupivacaine Liposome Injection Sales YoY (2019-2030) & (K Units)

Figure 25. China Bupivacaine Liposome Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 26. Asia (excluding China) Bupivacaine Liposome Injection Sales YoY (2019-2030) & (K Units)

Figure 27. Asia (excluding China) Bupivacaine Liposome Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 28. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales YoY (2019-2030) & (K Units)

Figure 29. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue YoY (2019-2030) & (US$ Million)

Figure 30. Global Bupivacaine Liposome Injection Sales Share by Manufacturers (2023)

Figure 31. The Bupivacaine Liposome Injection Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 32. Global Bupivacaine Liposome Injection Revenue Share by Manufacturers (2023)

Figure 33. The Top 5 and 10 Largest Manufacturers of Bupivacaine Liposome Injection in the World: Market Share by Bupivacaine Liposome Injection Revenue in 2023

Figure 34. Global Bupivacaine Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 35. Global Bupivacaine Liposome Injection Sales Market Share by Type (2019-2030)

Figure 36. Global Bupivacaine Liposome Injection Revenue Market Share by Type (2019-2030)

Figure 37. Global Bupivacaine Liposome Injection Sales Market Share by Application (2019-2030)

Figure 38. Global Bupivacaine Liposome Injection Revenue Market Share by Application (2019-2030)

Figure 39. US & Canada Bupivacaine Liposome Injection Sales Market Share by Type (2019-2030)

Figure 40. US & Canada Bupivacaine Liposome Injection Revenue Market Share by Type (2019-2030)

Figure 41. US & Canada Bupivacaine Liposome Injection Sales Market Share by Application (2019-2030)

Figure 42. US & Canada Bupivacaine Liposome Injection Revenue Market Share by Application (2019-2030)

Figure 43. US & Canada Bupivacaine Liposome Injection Revenue Share by Country (2019-2030)

Figure 44. US & Canada Bupivacaine Liposome Injection Sales Share by Country (2019-2030)

Figure 45. US Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 46. Canada Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 47. Europe Bupivacaine Liposome Injection Sales Market Share by Type (2019-2030)

Figure 48. Europe Bupivacaine Liposome Injection Revenue Market Share by Type (2019-2030)

Figure 49. Europe Bupivacaine Liposome Injection Sales Market Share by Application (2019-2030)

Figure 50. Europe Bupivacaine Liposome Injection Revenue Market Share by Application (2019-2030)

Figure 51. Europe Bupivacaine Liposome Injection Revenue Share by Country (2019-2030)

Figure 52. Europe Bupivacaine Liposome Injection Sales Share by Country (2019-2030)

Figure 53. Germany Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 54. France Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 55. U.K. Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 56. Italy Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 57. Russia Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 58. China Bupivacaine Liposome Injection Sales Market Share by Type (2019-2030)

Figure 59. China Bupivacaine Liposome Injection Revenue Market Share by Type (2019-2030)

Figure 60. China Bupivacaine Liposome Injection Sales Market Share by Application (2019-2030)

Figure 61. China Bupivacaine Liposome Injection Revenue Market Share by Application (2019-2030)

Figure 62. Asia Bupivacaine Liposome Injection Sales Market Share by Type (2019-2030)

Figure 63. Asia Bupivacaine Liposome Injection Revenue Market Share by Type (2019-2030)

Figure 64. Asia Bupivacaine Liposome Injection Sales Market Share by Application (2019-2030)

Figure 65. Asia Bupivacaine Liposome Injection Revenue Market Share by Application (2019-2030)

Figure 66. Asia Bupivacaine Liposome Injection Revenue Share by Region (2019-2030)

Figure 67. Asia Bupivacaine Liposome Injection Sales Share by Region (2019-2030)

Figure 68. Japan Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 69. South Korea Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 70. China Taiwan Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 71. Southeast Asia Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 72. India Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 73. Australia Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 74. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales Market Share by Type (2019-2030)

Figure 75. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue Market Share by Type (2019-2030)

Figure 76. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales Market Share by Application (2019-2030)

Figure 77. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue Market Share by Application (2019-2030)

Figure 78. Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue Share by Country (2019-2030)

Figure 79. Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales Share by Country (2019-2030)

Figure 80. Brazil Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 81. Mexico Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 82. Turkey Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 83. Israel Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 84. GCC Countries Bupivacaine Liposome Injection Revenue (2019-2030) & (US$ Million)

Figure 85. Bupivacaine Liposome Injection Value Chain

Figure 86. Bupivacaine Liposome Injection Production Process

Figure 87. Channels of Distribution (Direct Vs Distribution)

Figure 88. Bottom-up and Top-down Approaches for This Report

Figure 89. Data Triangulation

Figure 90. Key Executives Interviewed

This research report focuses on the Bupivacaine Liposome Injection Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Bupivacaine Liposome Injection Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Bupivacaine Liposome Injection Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
  • 1.2.2 133mg per Vial
  • 1.2.3 266mg per Vial
• 1.3 Market by Application
  • 1.3.1 Global Bupivacaine Liposome Injection Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
  • 1.3.2 Local Anesthesia
  • 1.3.3 Postoperative Analgesia
  • 1.3.4 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Executive Summary

• 2.1 Global Bupivacaine Liposome Injection Revenue Estimates and Forecasts 2019-2030
• 2.2 Global Bupivacaine Liposome Injection Revenue by Region
  • 2.2.1 Global Bupivacaine Liposome Injection Revenue by Region: 2019 VS 2023 VS 2030
  • 2.2.2 Global Bupivacaine Liposome Injection Revenue by Region (2019-2024)
  • 2.2.3 Global Bupivacaine Liposome Injection Revenue by Region (2025-2030)
  • 2.2.4 Global Bupivacaine Liposome Injection Revenue Market Share by Region (2019-2030)
• 2.3 Global Bupivacaine Liposome Injection Sales Estimates and Forecasts 2019-2030
• 2.4 Global Bupivacaine Liposome Injection Sales by Region
  • 2.4.1 Global Bupivacaine Liposome Injection Sales by Region: 2019 VS 2023 VS 2030
  • 2.4.2 Global Bupivacaine Liposome Injection Sales by Region (2019-2024)
  • 2.4.3 Global Bupivacaine Liposome Injection Sales by Region (2025-2030)
  • 2.4.4 Global Bupivacaine Liposome Injection Sales Market Share by Region (2019-2030)
• 2.5 US & Canada
• 2.6 Europe
• 2.7 China
• 2.8 Asia (excluding China)
• 2.9 Middle East, Africa and Latin America

3 Competition by Manufacturers

• 3.1 Global Bupivacaine Liposome Injection Sales by Manufacturers
  • 3.1.1 Global Bupivacaine Liposome Injection Sales by Manufacturers (2019-2024)
  • 3.1.2 Global Bupivacaine Liposome Injection Sales Market Share by Manufacturers (2019-2024)
  • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Bupivacaine Liposome Injection in 2023
• 3.2 Global Bupivacaine Liposome Injection Revenue by Manufacturers
  • 3.2.1 Global Bupivacaine Liposome Injection Revenue by Manufacturers (2019-2024)
  • 3.2.2 Global Bupivacaine Liposome Injection Revenue Market Share by Manufacturers (2019-2024)
  • 3.2.3 Global Top 10 and Top 5 Companies by Bupivacaine Liposome Injection Revenue in 2023
• 3.3 Global Key Players of Bupivacaine Liposome Injection, Industry Ranking, 2021 VS 2022
• 3.4 Global Bupivacaine Liposome Injection Sales Price by Manufacturers (2019-2024)
• 3.5 Analysis of Competitive Landscape
  • 3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 3.5.2 Global Bupivacaine Liposome Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 3.6 Global Key Manufacturers of Bupivacaine Liposome Injection, Manufacturing Base Distribution and Headquarters
• 3.7 Global Key Manufacturers of Bupivacaine Liposome Injection, Product Offered and Application
• 3.8 Global Key Manufacturers of Bupivacaine Liposome Injection, Date of Enter into This Industry
• 3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

• 4.1 Global Bupivacaine Liposome Injection Sales by Type
  • 4.1.1 Global Bupivacaine Liposome Injection Historical Sales by Type (2019-2024)
  • 4.1.2 Global Bupivacaine Liposome Injection Forecasted Sales by Type (2025-2030)
  • 4.1.3 Global Bupivacaine Liposome Injection Sales Market Share by Type (2019-2030)
• 4.2 Global Bupivacaine Liposome Injection Revenue by Type
  • 4.2.1 Global Bupivacaine Liposome Injection Historical Revenue by Type (2019-2024)
  • 4.2.2 Global Bupivacaine Liposome Injection Forecasted Revenue by Type (2025-2030)
  • 4.2.3 Global Bupivacaine Liposome Injection Revenue Market Share by Type (2019-2030)
• 4.3 Global Bupivacaine Liposome Injection Price by Type
  • 4.3.1 Global Bupivacaine Liposome Injection Price by Type (2019-2024)
  • 4.3.2 Global Bupivacaine Liposome Injection Price Forecast by Type (2025-2030)

5 Market Size by Application

• 5.1 Global Bupivacaine Liposome Injection Sales by Application
  • 5.1.1 Global Bupivacaine Liposome Injection Historical Sales by Application (2019-2024)
  • 5.1.2 Global Bupivacaine Liposome Injection Forecasted Sales by Application (2025-2030)
  • 5.1.3 Global Bupivacaine Liposome Injection Sales Market Share by Application (2019-2030)
• 5.2 Global Bupivacaine Liposome Injection Revenue by Application
  • 5.2.1 Global Bupivacaine Liposome Injection Historical Revenue by Application (2019-2024)
  • 5.2.2 Global Bupivacaine Liposome Injection Forecasted Revenue by Application (2025-2030)
  • 5.2.3 Global Bupivacaine Liposome Injection Revenue Market Share by Application (2019-2030)
• 5.3 Global Bupivacaine Liposome Injection Price by Application
  • 5.3.1 Global Bupivacaine Liposome Injection Price by Application (2019-2024)
  • 5.3.2 Global Bupivacaine Liposome Injection Price Forecast by Application (2025-2030)

6 US & Canada

• 6.1 US & Canada Bupivacaine Liposome Injection Market Size by Type
  • 6.1.1 US & Canada Bupivacaine Liposome Injection Sales by Type (2019-2030)
  • 6.1.2 US & Canada Bupivacaine Liposome Injection Revenue by Type (2019-2030)
• 6.2 US & Canada Bupivacaine Liposome Injection Market Size by Application
  • 6.2.1 US & Canada Bupivacaine Liposome Injection Sales by Application (2019-2030)
  • 6.2.2 US & Canada Bupivacaine Liposome Injection Revenue by Application (2019-2030)
• 6.3 US & Canada Bupivacaine Liposome Injection Market Size by Country
  • 6.3.1 US & Canada Bupivacaine Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030
  • 6.3.2 US & Canada Bupivacaine Liposome Injection Revenue by Country (2019-2030)
  • 6.3.3 US & Canada Bupivacaine Liposome Injection Sales by Country (2019-2030)
  • 6.3.4 US
  • 6.3.5 Canada

7 Europe

• 7.1 Europe Bupivacaine Liposome Injection Market Size by Type
  • 7.1.1 Europe Bupivacaine Liposome Injection Sales by Type (2019-2030)
  • 7.1.2 Europe Bupivacaine Liposome Injection Revenue by Type (2019-2030)
• 7.2 Europe Bupivacaine Liposome Injection Market Size by Application
  • 7.2.1 Europe Bupivacaine Liposome Injection Sales by Application (2019-2030)
  • 7.2.2 Europe Bupivacaine Liposome Injection Revenue by Application (2019-2030)
• 7.3 Europe Bupivacaine Liposome Injection Market Size by Country
  • 7.3.1 Europe Bupivacaine Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030
  • 7.3.2 Europe Bupivacaine Liposome Injection Revenue by Country (2019-2030)
  • 7.3.3 Europe Bupivacaine Liposome Injection Sales by Country (2019-2030)
  • 7.3.4 Germany
  • 7.3.5 France
  • 7.3.6 U.K.
  • 7.3.7 Italy
  • 7.3.8 Russia

8 China

• 8.1 China Bupivacaine Liposome Injection Market Size by Type
  • 8.1.1 China Bupivacaine Liposome Injection Sales by Type (2019-2030)
  • 8.1.2 China Bupivacaine Liposome Injection Revenue by Type (2019-2030)
• 8.2 China Bupivacaine Liposome Injection Market Size by Application
  • 8.2.1 China Bupivacaine Liposome Injection Sales by Application (2019-2030)
  • 8.2.2 China Bupivacaine Liposome Injection Revenue by Application (2019-2030)

9 Asia (excluding China)

• 9.1 Asia Bupivacaine Liposome Injection Market Size by Type
  • 9.1.1 Asia Bupivacaine Liposome Injection Sales by Type (2019-2030)
  • 9.1.2 Asia Bupivacaine Liposome Injection Revenue by Type (2019-2030)
• 9.2 Asia Bupivacaine Liposome Injection Market Size by Application
  • 9.2.1 Asia Bupivacaine Liposome Injection Sales by Application (2019-2030)
  • 9.2.2 Asia Bupivacaine Liposome Injection Revenue by Application (2019-2030)
• 9.3 Asia Bupivacaine Liposome Injection Market Size by Region
  • 9.3.1 Asia Bupivacaine Liposome Injection Revenue by Region: 2019 VS 2023 VS 2030
  • 9.3.2 Asia Bupivacaine Liposome Injection Revenue by Region (2019-2030)
  • 9.3.3 Asia Bupivacaine Liposome Injection Sales by Region (2019-2030)
  • 9.3.4 Japan
  • 9.3.5 South Korea
  • 9.3.6 China Taiwan
  • 9.3.7 Southeast Asia
  • 9.3.8 India
  • 9.3.9 Australia

10 Middle East, Africa and Latin America

• 10.1 Middle East, Africa and Latin America Bupivacaine Liposome Injection Market Size by Type
  • 10.1.1 Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales by Type (2019-2030)
  • 10.1.2 Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Type (2019-2030)
• 10.2 Middle East, Africa and Latin America Bupivacaine Liposome Injection Market Size by Application
  • 10.2.1 Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales by Application (2019-2030)
  • 10.2.2 Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Application (2019-2030)
• 10.3 Middle East, Africa and Latin America Bupivacaine Liposome Injection Market Size by Country
  • 10.3.1 Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Country: 2019 VS 2023 VS 2030
  • 10.3.2 Middle East, Africa and Latin America Bupivacaine Liposome Injection Revenue by Country (2019-2030)
  • 10.3.3 Middle East, Africa and Latin America Bupivacaine Liposome Injection Sales by Country (2019-2030)
  • 10.3.4 Brazil
  • 10.3.5 Mexico
  • 10.3.6 Turkey
  • 10.3.7 Israel
  • 10.3.8 GCC Countries

11 Corporate Profile

• 11.1 Pacira Pharmaceuticals
  • 11.1.1 Pacira Pharmaceuticals Company Information
  • 11.1.2 Pacira Pharmaceuticals Overview
  • 11.1.3 Pacira Pharmaceuticals Bupivacaine Liposome Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.1.4 Pacira Pharmaceuticals Bupivacaine Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.1.5 Pacira Pharmaceuticals Recent Developments
• 11.2 Jiangsu Hengrui Pharma
  • 11.2.1 Jiangsu Hengrui Pharma Company Information
  • 11.2.2 Jiangsu Hengrui Pharma Overview
  • 11.2.3 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Sales, Price, Revenue and Gross Margin (2019-2024)
  • 11.2.4 Jiangsu Hengrui Pharma Bupivacaine Liposome Injection Product Model Numbers, Pictures, Descriptions and Specifications
  • 11.2.5 Jiangsu Hengrui Pharma Recent Developments

12 Industry Chain and Sales Channels Analysis

• 12.1 Bupivacaine Liposome Injection Industry Chain Analysis
• 12.2 Bupivacaine Liposome Injection Key Raw Materials
  • 12.2.1 Key Raw Materials
  • 12.2.2 Raw Materials Key Suppliers
• 12.3 Bupivacaine Liposome Injection Production Mode & Process
• 12.4 Bupivacaine Liposome Injection Sales and Marketing
  • 12.4.1 Bupivacaine Liposome Injection Sales Channels
  • 12.4.2 Bupivacaine Liposome Injection Distributors
• 12.5 Bupivacaine Liposome Injection Customers

13 Bupivacaine Liposome Injection Market Dynamics

• 13.1 Bupivacaine Liposome Injection Industry Trends
• 13.2 Bupivacaine Liposome Injection Market Drivers
• 13.3 Bupivacaine Liposome Injection Market Challenges
• 13.4 Bupivacaine Liposome Injection Market Restraints

14 Key Findings in the Global Bupivacaine Liposome Injection Study

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 15.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Author Details
• 15.3 Disclaimer